Bayer AG NA
Research Bayer AG NA (BAYN) on Bullrun: market cap EUR 47.20B, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBAYN
- ExchangeHM
- CountryGermany
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 47.20B
- Dividend yield0.2%
- Financial periodQ1 2026
- RevenueEUR 13.41B
- Net incomeEUR 2.76B
- Free cash flow-EUR 2.21B
- Gross margin61.0%
Valuation Snapshot
latest market cap is EUR 47.20B; dividend yield is 0.2%.
Peer valuation comparison
Latest dividend yield is 0.23% versus a Healthcare sector median of 2.11% (89.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 45.58B | -EUR 3.62B | EUR 3.44B | 58.8% | n/a | EUR 6.67B | EUR 36.45B | EUR 25.95B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 47.20B | n/a | 0.2% | 0.11 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.11 EUR, yield 0.2%.
About Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bayer AG NA's market cap?
Bayer AG NA's market capitalization is EUR 47.20B.
Does Bayer AG NA pay a dividend?
Bayer AG NA has a dividend yield of 0.2%.
What does Bayer AG NA do?
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.